Zuellig Pharma expands partnership with Lundbeck to support commercialization of neuro-psychiatric health solutions in Asia

Zuellig Pharma expands partnership with Lundbeck to support commercialization of neuro-psychiatric health solutions in Asia

SINGAPORE - Media OutReach Newswire - 16 December 2025 - Zuellig Pharma, a leading healthcare solutions company in Asia, today announced that it has expanded its partnership with H. Lundbeck A/S ("Lundbeck"), a biopharmaceutical company focusing exclusively on brain health.

Zuellig Pharma deepens Lundbeck partnership for Asia neuroscience push

SINGAPORE - Media OutReach Newswire - 16 December 2025 -Zuellig Pharma, a leading healthcare solutions company in Asia, today announced that it has expanded its partnership with H. Lundbeck A/S ("Lundbeck"), a biopharmaceutical company focusing exclusively on brain health. Under this new agreement, Zuellig Pharma will take on the role of agency partner to commercialize Lundbeck's portfolio of products – including leading brands such as Lexapro®,…

Zuellig Pharma expands partnership with Lundbeck to support commercialization of neuro-psychiatric health solutions in Asia - The Morning Sun

SINGAPORE - Media OutReach Newswire - 16 December 2025 - Zuellig Pharma, a leading healthcare solutions company in Asia, today announced that it has expanded its partnership with H. Lundbeck A/S ("Lundbeck"), a biopharmaceutical company focusing exclusively on brain health. Under this new agreement, Zuellig Pharma will take on the role of agency partner to commercialize Lundbeck's portfolio of products – including leading brands such as Lexapro®…